Hydrocodone should not be administered within 14 days of stopping an MAOI.
PREGNANCY AND BREASTFEEDING SAFETY: There are no adequate studies of hydrocodone in pregnant women. Hydrocodone is excreted in breast milk, and, therefore, should be used cautiously by nursing mothers.
STORAGE: Hydrocodone/homatropine should be stored at room temperature, between 15 C to 30 C (59 F to 86 F).
- The dose for adults and children older than 12 years is one tablet (5 mg/1.5 mg) orally every 4 to 6 hours. The maximum dose is 30 mg/9 mg (6 tablets) in 24 hours.
- Children 6 to 12 years of age receive a 1/2 tablet (2.5 mg/0.75 mg) every 4 to 6 hours not to exceed 3 tablets (15 mg/4.5 mg)
DRUG CLASS AND MECHANISM:
- Hydrocodone is an opioid narcotic pain-reliever cough suppressant that is similar to codeine, oxycodone, morphine, methadone, fentanyl, and other opioids.
- Hydrocodone, like other opioids, stimulates receptors on nerves in the brain to increase the threshold to pain (the amount of stimulation it takes to feel pain) and reduce the perception of pain (the perceived importance of the pain).
- It also works directly on the cough center in the brain to reduce cough.
- Homatropine blocks the action of acetylcholine, a chemical (neurotransmitter) that nerves use to communicate. It is added in low doses to discourage deliberate overdoses of hydrocodone.
- The FDA approved hydrocodone/homatropine in July 1985.
Medically reviewed by Eni Williams, PharmD
REFERENCE: FDA Prescribing Information.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.